◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocksD › DSFIR

DSM-Firmenich AG (DSFIR) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Basic Materials · Specialty Chemicals · DATA UPDATED 2026-08-16

DSM-Firmenich AG (DSFIR) operates in the Specialty Chemicals industry and is headquartered in Kaiseraugst, Switzerland with about 20,786 employees. Its market capitalization is roughly €22 billion. In the fiscal year ended 2025-12-31, DSFIR reported €9.0B in revenue and (€1.1B) in net income.

DSM-Firmenich AG provides nutrition, health, and beauty solutions in Switzerland, the Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. The company operates through Perfumery & Beauty; Taste, Texture & Health; and Health, Nutrition & Care segments.

Interactive charts & full statements →

DSFIR Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Revenue€9.0B€9.1B€10.6B€8.4B
Gross Profit€3.5B€3.6B€2.6B€2.7B
Operating Income (EBIT)€632M€551M(€507M)€657M
Net Income(€1.1B)€250M€2.1B€1.7B

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

DSFIR Free Cash Flow History

Cash flow2025-12-312024-12-312023-12-312022-12-31
Dividends Paid(€718M)(€667M)(€582M)(€345M)

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

DSFIR Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-31
Total Assets€29.3B€33.7B€34.3B€17.4B
Total Liabilities€10.9B€11.1B€11.2B€6.6B

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive DSFIR viewer.

Other Companies in Specialty Chemicals

← DSCVAll “D” companiesDSG →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.